Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
ALLEGRA ALLERGY
Generic name / active ingredient
fexofenadine hydrochloride
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-24

Copy from the pack in hand

Source-linked reading points

  • Check ALLEGRA ALLERGY, fexofenadine hydrochloride, 180 mg per tablet, oral-tablet form, 30-tablet pack and target market together. 180 mg is the label strength for this exact tablet, not a web answer to anyone's tablet count.
  • The same U.S. label also lists 60 mg and 180 mg tablets. A shared ALLEGRA name, antihistamine wording or hour wording does not make products self-convertible, combinable or interchangeable by tablet count, experience or milligrams; ALLEGRA-D combinations are not the same product.
  • The label tells readers with kidney disease, pregnancy or breastfeeding to ask a professional first; it also warns against taking it at the same time as aluminum- or magnesium-containing antacids and against taking it with fruit juices. With these circumstances, multiple allergy/cold products or uncertainty about use, take the full medicine list and actual pack to a pharmacist or clinician rather than self-adjusting.
  • A package image, colour, imprint or brand name can only help locate a source; it cannot authenticate a product, establish current approval or decide individual suitability. With a suspected reaction, overdose, worsening symptoms or uncertainty about the next step, use local medical channels.

Reviewed presentation examples — compare every field

  • Fexofenadine hydrochloride 180 mg per tablet; 30-tablet plastic-bottle cartonNDC 41167-4120-3

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-24
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image